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Low-density lipoprotein receptor-related protein 1 (LRP1) is a large, endocytic cell
surface receptor that is highly expressed by oligodendrocyte progenitor cells (OPCs) and
LRP1 expression is rapidly downregulated as OPCs differentiate into oligodendrocytes
(OLs). We report that the conditional deletion of Lrp1 from adult mouse OPCs
(Pdgfrα-CreER :: Lrp1fl/fl) increases the number of newborn, mature myelinating OLs
added to the corpus callosum and motor cortex. As these additional OLs extend a
normal number of internodes that are of a normal length, Lrp1-deletion increases adult
myelination. OPC proliferation is also elevated following Lrp1 deletion in vivo, however,
this may be a secondary, homeostatic response to increased OPC differentiation,
as our in vitro experiments show that LRP1 is a direct negative regulator of OPC
differentiation, not proliferation. Deleting Lrp1 from adult OPCs also increases the
number of newborn mature OLs added to the corpus callosum in response to
cuprizone-induced demyelination. These data suggest that the selective blockade of
LRP1 function on adult OPCs may enhance myelin repair in demyelinating diseases
such as multiple sclerosis.
Keywords: LRP1, oligodendrocyte, myelin, proliferation, NG2 glia, remyelination, cuprizone, alpha-2-
macroglobulin
INTRODUCTION
Oligodendrocytes (OLs) myelinate the central nervous system (CNS) to facilitate the saltatory
conduction of action potentials and provide essential metabolic support to axons (reviewed by
Pepper et al., 2018). The majority of OLs are produced from oligodendrocyte progenitor cells
(OPCs) during development, however, adult OPCs also produce new OLs (Dimou et al., 2008;
Rivers et al., 2008; Zhu et al., 2008; Kang et al., 2010; Hughes et al., 2013; Young et al., 2013;
Hill et al., 2018) that add additional myelin to the mature CNS (Hill et al., 2018; Hughes et al.,
2018). A number of signaling pathways have been identified that regulate developmental and adult
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GRAPHICAL ABSTRACT | LRP1 regulates adult oligodendrogenesis and remyelination.
OPC behavior and oligodendrogenesis, including Notch1
(Genoud et al., 2002; Givogri et al., 2002; Zhang et al., 2009),
fibroblast growth factor 2 (Murtie et al., 2005; Zhou et al., 2006;
Murcia-Belmonte et al., 2014), mammalian target of rapamycin
(Zou et al., 2014; Jiang et al., 2016; Grier et al., 2017) and platelet-
derived growth factor A (McKinnon, 2005; Rajasekharan, 2008;
Chew et al., 2010) signaling. However, microarray (Cahoy et al.,
2008) and RNA sequencing (Zhang et al., 2014; Hrvatin et al.,
2018) experiments have uncovered a number of additional genes
that are differentially expressed across OL development and have
an unknown or partly characterized regulatory function in the
OL lineage. One such gene is the low-density lipoprotein receptor
related protein 1 (Lrp1).
LRP1, also known as CD91 or the α2 macroglobulin
(α2M) receptor, is highly expressed by OPCs and is rapidly
downregulated during OL differentiation (Auderset et al.,
2016a). This large cell surface receptor, comprising a 515 kDa
extracellular α-chain and an 85 kDa β-chain, could influence
OPC behavior in a number of ways, as it interacts with a
large variety of ligands, as well as extracellular and intracellular
proteins, to facilitate signal transduction (Auderset et al.,
2016b; Bres and Faissner, 2019). In other cell types, LRP1
acts as a receptor or co-receptor to initiate intracellular signal
transduction, but also facilitates ligand endocytosis, transcytosis,
or processing (Cam et al., 2005; Parkyn et al., 2008; Su et al., 2008;
Yamamoto et al., 2014; Liu et al., 2017; Van Gool et al., 2019;
Rauch et al., 2020), as well as receptor, channel and transporter
trafficking (Parkyn et al., 2008; Maier et al., 2013; Nakajima
et al., 2013; Liu et al., 2015; Boyé et al., 2017; Kadurin et al., 2017;
Wujak et al., 2018) to influence blood brain barrier permeability
(Polavarapu et al., 2007), lipid metabolism, glucose homeostasis,
neuroinflammation (Brifault et al., 2017, 2019; Actis Dato and
Chiabrando, 2018) and synaptic plasticity (Zhuo et al., 2000).
Lrp1 knockout mice are embryonic lethal, as the blastocysts
fail to implant (Herz et al., 1992), but the conditional deletion
of Lrp1 from cultured mouse neural stem and progenitor cells
(NSPCs) impairs NSPC proliferation and reduces the number
of OL lineage cells generated (Hennen et al., 2013; Safina et al.,
2016). Furthermore, the conditional deletion of Lrp1 from Olig2+
cells (Olig2-Cre :: Lrp1fl/fl mice) impairs oligodendrogenesis
in the developing mouse optic nerve, ultimately reducing the
proportion of axons that are myelinated and myelin thickness by
postnatal day (P)21 (Lin et al., 2017). As ∼20% of optic nerve
axons are subsequently myelinated in control and Lrp1-deleted
mice between P21 and P56, and the discrepancy in g-ratio lessens
(Lin et al., 2017), this phenotype may represent a developmental
delay in optic nerve myelination. This idea is supported by
myelination being grossly normal in the brain and optic nerve of
young adult mice following the developmental deletion of Lrp1
from Olig1+ cells (Fernandez-Castaneda et al., 2019).
As OPC physiology changes considerably between
development and adulthood, and can also differ between
CNS regions (Velez-Fort et al., 2010; Pitman et al., 2019; Spitzer
et al., 2019), we examined the importance of LRP1 for adult
OPC function. The conditional deletion of Lrp1 from adult
OPCs (Pdgfrα-CreER :: Lrp1fl/fl) revealed that LRP1 is a negative
regulator of oligodendrogenesis in the healthy adult mouse
brain. Lrp1 deletion was associated with an increase in adult
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OPC proliferation and a significant increase in the number of
newborn mature OLs added to the cortex and corpus callosum
(see Graphical Abstract). Furthermore, Lrp1 deletion was
associated with a larger number of newborn mature OLs being
detected in the corpus callosum of cuprizone fed-mice and less
of the corpus callosum showed overt demyelination.
MATERIALS AND METHODS
Transgenic Mice and Their Housing
All animal experiments were approved by the University
of Tasmania Animal Ethics (A0016151) and Institutional
Biosafety Committees and were carried out in accordance
with the Australian code of practice for the care and use of
animals for scientific purposes. Pdgfrα-CreERT 2 mice (Rivers
et al., 2008) were a kind gift from Prof William D Richardson
(University College London). Pdgfrα-CreERTM (Kang et al.,
2010; RRID:IMSR_JAX:018280), Pdgfrα-H2BGFP [Pdgfrα-
histGFP (Hamilton et al., 2003); RRID:IMSR_JAX:007669] and
Lrp1fl/fl (Herz et al., 1992; RRID:IMSR_JAX:012604) mice were
purchased from Jackson Laboratories. Cre-sensitive Rosa26-YFP
(Srinivas et al., 2001; RRID: IMSR_JAX:006148) and Tau-mGFP
(Hippenmeyer et al., 2005; RRID:IMSR_JAX021162) reporter
mice were also purchased from Jackson laboratories. Mice
were maintained on a C57BL/6 background and inter-crossed
to generate male and female offspring for experimental use.
All mice were weaned >P30 to ensure appropriate myelin
development, were group housed with same-sex littermates
in Optimice micro-isolator cages (Animal Care Systems, CO,
United States) and were maintained on a 12-h light/dark cycle at
20◦C, with uninhibited access to food and water.
Please note that two distinct Pdgfrα-CreER transgenic mouse
lines were used in this study: the Pdgfrα-CreERTM transgenic
mouse line (Kang et al., 2010) was used for the majority
of experiments and the lower efficiency (LE) Pdgfrα-CreERT 2
transgenic mouse line (Rivers et al., 2008), was used to
perform the Tau-mGFP lineage tracing experiments, as we have
previously demonstrated that the Pdgfrα-CreERTM transgenic
mouse line cannot be used to induce OPC-specific recombination
of the Tau-mGFP reporter, despite achieving the OPC-specific
recombination of other transgenes (Pitman et al., 2019).
Genomic DNA Extraction and PCR
Amplification
For genotyping, ear biopsies were digested overnight in DNA
extraction buffer (100 mM Tris-HCl, 5 mM EDTA, 200 mM NaCl,
0.2% SDS and 120 ng of proteinase k) at 55◦C. Cellular and
histone proteins were precipitated by incubating samples with
6 M ammonium acetate (Sigma; A1542) on ice and the DNA was
precipitated from the supernatant by incubating with isopropyl
alcohol (Sigma; I9516). The DNA pellet was washed in 70%
ethanol (Sigma; E7023), resuspended in sterile MilliQ water and
used as template DNA for polymerase chain reaction (PCR). Each
25 µL reaction contained: 50–100 ng DNA; 0.5 µL of each primer
(100 nmol/mL, GeneWorks); 12.5 µL of GoTaq green master mix
(Promega) and MilliQ water. The following primers were used:
Lrp1 5′ CATAC CCTCT CAAACC CCTT CCTG and Lrp1 3′
GCAAG CTCC CTGCTCA GACC TGGA; Rosa26 wildtype 5′
AAAGT CGCTC TGAGT TGTTAT, Rosa26 wildtype 3′ GGAGC
GGGAG AAATG GATATG and Rosa26 mutant 5′ GCGAA
GAGTT TGTCC TCAACC; Cre 5′ CAGGT CTCAG GAGCT
ATGTC CAATT TACTG ACCGTA and Cre 3′ GGTGT TATAAG
CAATCC CCAGAA, or GFP 5′ CCCTG AAGTTC ATCTG
CACCAC and GFP 3′ TTCTC GTTGG GGTCT TTGCTC in
a program of: 94◦C for 4 min, and 34 cycles of 94◦C for 30′′,
60◦C for 45′′ (37 cycles for Rosa26-YFP genotyping) and 72◦C for
60′′, followed by 72◦C for 10 min. Following gel electrophoresis
[1% (w/v) agarose in TAE containing SYBR-safe (Thermo Fisher
Scientific)], the DNA products were visualized using an Image
Station 4000 M PRO gel system running Carestream software.
Tamoxifen Preparation and
Administration
Tamoxifen (Sigma) was dissolved in corn oil (Sigma) to a
concentration of 40 mg/ml by sonication in a water bath for 2 h
at 21◦C. Adult mice received tamoxifen (300 mg/kg) daily by oral
gavage for 4 consecutive days.
Tissue Preparation and
Immunohistochemistry
Mice were terminally anesthetized with an intraperitoneal (i.p)
injection of sodium pentobarbital (30 mg/kg, Ilium) and were
transcardially perfused with 4% (w/v) paraformaldehyde (PFA;
Sigma) in phosphate buffered saline (PBS). Brains were cut into
2 mm-thick coronal slices using a 1 mm brain matrix (Kent
Scientific) before being post-fixed in 4% (w/v) PFA in PBS at 21◦C
for 90 min. Tissue was cryoprotected in 20% sucrose (Sigma) in
PBS and transferred to OCT (Thermo Fisher Scientific) before
being snap frozen in liquid nitrogen and stored at−80◦C.
Thirty µm coronal brain cryosections were collected
and processed as floating sections (as per O’Rourke et al.,
2016). Cryosections were exposed to primary antibodies
diluted in blocking solution [10% (v/v) fetal calf serum
(FCS, Serana) and 0.05% (v/v) triton ×100 in PBS] and
incubated overnight at 4◦C on an orbital shaker. Primary
antibodies included: rabbit anti-LRP1 (1:500, Abcam ab92544;
RRID:AB_2234877); goat anti-PDGFRα (1:100, R&D Systems
AF1062; RRID:AB_2236879); rabbit anti-ASPA (1:200, Abcam
ab97454; RRID:AB_10679051); rabbit anti-LRP2 (1:100, Abcam
ab76969, RRID:AB_10673466); rat anti-GFP (1:2000, Nacalai
Tesque 04404-26; RRID:AB_2314545); rat anti-MBP (1:100,
Millipore MAB386; RRID:AB_94975), rabbit anti-OLIG2
(1:400, Abcam ab9610; RRID:AB_570666); guinea pig anti-IBA1
(1:250, Synaptic Systems 234004; RRID:AB_2493179), and
mouse anti-NaBC1 (BCAS1; 1:200, Santa Cruz sc-136342;
RRID:AB_10839529). After washing in PBS, cryosections were
incubated with secondary antibodies conjugated to Fluors
(Life Technologies Corporation), diluted in blocking solution,
overnight at 4◦C on an orbital shaker. Secondary antibodies
included: donkey anti-rat 488 (1:500; RRID: AB_2535794);
donkey anti-rabbit 488 (1:1000; RRID: AB_2535792); donkey
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anti-rabbit 568 (1:1000; RRID: AB_2534017); donkey anti-
rabbit 647 (1:1000; RRID: AB_2536183); donkey anti-goat 647
(1:1000; RRID: AB_2535864), donkey anti-mouse 647 (1:1000;
RRID AB_162542), or goat anti-guinea pig 488 (1:1000; RRID:
AB_2534117). Cell nuclei were visualized by the inclusion of
Hoechst 33342 (1:10,000, Invitrogen).
EdU Administration and Labeling
For the in vivo labeling of dividing cells, 5-Ethynly-2′-
deoxyuridine (EdU; E10415, Thermo Fisher Scientific) was
administered to mice via their drinking water at a concentration
of 0.2 mg/ml for up to 21 consecutive days [as per Clarke et al.
(2012)]. For in vitro labeling, cells were exposed to 2.5 µg/ml
EdU in complete OPC medium (see below) for 10 h before
the cells were fixed with 4% (w/v) PFA in PBS for 15 min at
21◦C. The EdU developing cocktail was prepared according to
the AlexaFluor-647 Click-IT EdU kit (Invitrogen) instructions,
and brain slices were exposed to the developing reagent for
45 min at 21◦C, while coverslips of cultured cells were exposed
for 15 min. EdU developing was performed immediately after
the secondary antibody was washed from tissue or cells during
immunohistochemistry or immunocytochemistry.
Primary OPC Culture and in vitro Gene
Deletion
The cortices of P1-10 mice were dissected into Earle’s Buffered
Salt Solution (EBSS; Invitrogen, 14155-063), diced into pieces
∼1 mm3 and digested in 0.06 mg/ml trypsin (Sigma, T4799) in
EBSS at 37◦C for 10 min. The trypsin was inactivated by the
addition of FCS, before the tissue was resuspended and triturated
in EBSS containing 0.12 mg/ml DNAseI (Sigma, 5025). The
cell preparation was filtered through a 40 µm sieve (Corning,
352340), centrifuged and resuspended in complete OPC medium
[20 ng/ml human PDGF-AA (Peprotech), 10 ng/ml basic
fibroblast growth factor (R&D Systems), 10 ng/ml human ciliary
neurotrophic factor (Peprotech), 5 µg/ml N-acetyl cysteine
(Sigma), 1 ng/ml neurotrophin-3 (Peprotech), 1 ng/ml biotin
(Sigma), 10 µM forskolin (Sigma), 1× penicillin/streptomycin
(Invitrogen), 2% B27 (Invitrogen), 50 µg/ml insulin (Sigma),
600 ng/ml progesterone (Sigma), 1 mg/ml transferrin (Sigma),
1 mg/ml BSA (Sigma), 400 ng/ml sodium selenite (Sigma)
and 160 µg/ml putrescine (Sigma) in DMEM+Glutamax
(Invitrogen)]. Cells were plated into 6 well plates coated with
>300,000 MW Poly D Lysine (PDL; Sigma, P7405). After 7 DIV,
the cells were dislodged by incubating in 1:5 TrypLE (Gibco) in
EBSS for ∼10 min at 37◦C, before the trypsin was inactivated by
the addition of FCS, and cells were collected into EBSS. OPCs
were then purified by immunopanning as previously described
(Emery and Dugas, 2013). In brief, the cell suspension was
transferred to a petri dish pre-coated with anti-PDGFRα (BD
Pharmigen 558774; RRID:AB_397117) and the OPCs allowed
to adhere for 45 min at 21◦C. The non-adherent cells were
then removed by rinsing with EBSS and the purified OPCs were
stripped by treating with TrypLE diluted 1:5 with EBSS for 5 min
at 37◦C. The recovered cells were plated onto 13 mm glass
coverslips in complete OPC medium.
For experiments where Lrp1 was deleted in vitro, OPCs were
plated in complete OPC medium at a density of 20,000 cells
per PDL-treated 13 mm coverslip and allowed to settle for
2 days. OPCs were then exposed to 1 µM TAT-Cre (Excellgen,
EG-1001) in complete OPC medium at 37◦C/5% CO2 for
90 min. The TAT-Cre-containing medium was then removed
and replaced with fresh complete OPC medium and the cells
returned to the incubator for 48 h. To induce differentiation, the
complete OPC medium was removed and replaced with OPC
differentiation medium [complete OPC medium lacking PDGF-
AA and containing 4 µg/ml triiodothyronine (Sigma)] for 4 days
before cells were fixed by exposure to 4% PFA (w/v) in PBS for
15 min at 21◦C.
LRP1 ligands were reconstituted according to the
manufacturer’s instructions. Human recombinant
Apolipoprotein E4 (ApoE4; Sigma, A3234) was reconstituted to
0.7 mg/mL in sterile MQ water and was diluted to a concentration
of 203 nM in the culture medium. Human recombinant tissue
plasminogen activator (tPA; Abcam ab92637) was diluted to a
final concentration of 20 nM in the culture medium. Human
activated α-2 macroglobulin (∗α2M; Sigma, SRP6315) was
reconstituted in MilliQ water and diluted to a final concentration
of 60 mM in the culture medium.
Whole Cell Patch Clamp
Electrophysiology
Acute coronal brain slices (300 µm) were generated from adult
mice carrying the Pdgfrα-histGFP transgene using a VT1200s
vibratome (Leica) as previously described (Pitman et al., 2019).
Brain slices were transferred to a bath constantly perfused
(2 ml/min) with ∼21◦C artificial cerebral spinal fluid (ASCF)
containing: 119 mM NaCl, 1.6 mM KCl, 1 mM NaH2PO4,
26.2 mM NaHCO3, 1.4 mM MgCl2, 2.4 mM CaCl2, and
11 mM glucose (300 ± 5 mOsm/kg), saturated with 95%
O2/5% CO2, Whole cell patch clamp recordings of GFP+
cells in the motor cortex were collected using a HEKA Patch
Clamp EPC800 amplifier and pCLAMP 10.5 software (Molecular
devices; RRID: SCR_011323).
To record AMPA (α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid)/kainate receptor currents, recording
electrodes (3–6 M) were filled with an internal solution
containing: 125 mM Cs-methanesulfonate, 5 mM TEA-Cl, 2 mM
MgCl2, 8 mM HEPES, 9 mM EGTA, 10 mM phosphocreatine,
5 mM MgATP, and 1 mM Na2GTP, and set to a pH of 7.2
with CsOH and an osmolarity of 290 ± 5 mOsm/kg. Upon
breakthrough, cells were held at −50 mV and a series of voltage
steps (up to+30 mV) applied to determine the presence of
a voltage-gated sodium channel current. GFP+ cells with a
voltage-gated sodium current >100 pA were considered OPCs.
All subsequent recordings were undertaken in ACSF containing
50 µm (2R)-amino-5-phosphonovaleric acid (APV; Sigma) and
1 µM tetrodotoxin (TTX; Sigma). Cells were held at −60 mV
and currents elicited by applying 200 ms voltage steps from −80
to 20 mV (20 mV increments). After taking baseline recordings,
currents were then elicited in ACSF containing 100 µM kainate.
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The mean steady state current (last 100 ms) of each voltage
step was measured.
Voltage gated calcium channel (VGCC) current recordings
were made using solutions previously described (Pitman et al.,
2019). All other voltage gated currents (potassium and sodium)
were blocked. To record L-type VGCC currents, OPCs were
held at −50 mV and a series of 500 ms voltage steps (−60
to+30 mV) applied using a P/N subtraction protocol. The
current-density relationship is presented as the average steady
state current (the last 100 ms of the voltage steps) from ∼3
recordings per cell. To elicit currents through T-type VGCCs,
OPCs were held at −50 mV and the cell was hyperpolarized
to −120 mV for 200 ms before applying voltage steps from
−70 to 30 mV (Fulton et al., 2010; Haberlandt et al., 2011).
The maximum amplitude of the fast, transient inward current,
revealed by the brief hyperpolarization, was measured from ∼3
recordings per cell.
Access resistance was measured before and after all recordings
and an access resistance >20 M resulted in exclusion of
that recording. Due to the high membrane resistance of
OPCs (>1 G) during VGCC current recordings, recordings
were made without series resistance compensation. However,
series resistance compensation was applied for AMPA current
recordings (60–80%). Measurements were made from each data
file using Clampfit 10.5.
Cuprizone Administration and
Black-Gold Myelin Staining
Mice were transferred onto a diet of crushed mouse food
(Barrestock) containing 0.2% (w/w) cuprizone powder (C9012,
Sigma), which was refreshed every 2 days for 5 weeks. Mice
were perfusion fixed, their tissue processed as described above
and 30 µm coronal brain floating cryosections collected into
PBS. Cryosections were transferred onto glass microscope slides
(Superfrost) and allowed to dry before being rehydrated in MilliQ
water for 3 min and incubated with preheated 0.3% black-gold II
stain (Millipore, AG105) at 60◦C for 30 min. Slides were washed
twice with MilliQ water before being incubated with preheated
1% (v/v) sodium thiosulphate solution at 60◦C for 3 min, washed
in MilliQ water (3 × 2 min), dehydrated using a series of graded
alcohol steps, incubated in xylene (Sigma, 214736) for 3 min, and
mounted with DPX mounting medium (Sigma, 06522).
Microscopy and Statistical Analyses
Fluorescent labeling was visualized using an UltraView Spinning
Disk confocal microscope with Volocity software (Perkin Elmer,
Waltham, United States). The motor cortex and corpus callosum
were defined as regions of interest using anatomical markers
identified in the Allen Mouse Brain Atlas, in brain sections
collected between Bregma level 1.10 and −0.10 mm. Confocal
images were collected using standard excitation and emission
filters for DAPI, FITC (Alexa Fluor-488), TRITC (Alexa Fluor-
568) and CY5 (Alexa Fluor-647). To quantify cell density,
or the proportion of cells that proliferate or differentiate,
a 10× or 20× air objective was used to collect images with
2 µm z-spacing that spanned the defined region of interest
within a brain section. These images were stitched together using
Volocity software to create a single image of that region for
analysis. A minimum of 3 brain sections were imaged per mouse.
To quantify oligodendrocyte morphology and measure myelin
internodes a 40× (air) or 60× (water) objective was used to
collect images with 1 µm z-spacing of individual mGFP+ OLs
or single fields of view containing internodes within each region
of interest. Black-gold myelin staining was imaged using a light
microscope with a 2.5× objective and images were manually
stitched together using Adobe Photoshop CS6 to recreate the
region of interest. Cell counts were performed by manually
evaluating the labeling of individual cells and area measurements
were made by manually defining the region of interest within
Photoshop CS6 (Adobe, San Jose, United States) or Image J (NIH,
Bethesda, MD, United States). All measurements were made
blind to the experimental group and treatment conditions.
Statistical comparisons were made using GraphPad Prism 8.0
(La Jolla, CA, United States; RRID: SCR_002798). Data were first
assessed using the D’Agostino-Pearson normality test. Data that
were normally distributed were analyzed by a parametric test [t-
test, one-way analysis of variance (ANOVA) or two-way ANOVA
for group comparisons with a Bonferroni post hoc test], and data
that were not normally distributed were analyzed using a Mann–
Whitney U test or Kolmogorov–Smirnov test. Lesion size (black-
gold staining) data were analyzed using a t-test with a Welch’s
correction to account for the uneven variance between groups.
Data sets with n = 3 in any group were analyzed using parametric
tests, as the non-parametric equivalents rely on ranking and
are unreliable for small sample sizes (GraphPad Prism 8.0). To
determine the rate at which OPCs become labeled with EdU over
time, these data were analyzed by performing linear regression
analyses. Details of the statistical comparisons are provided in
each figure legend or in text when the data are not presented
graphically. Statistical significance was defined as p < 0.05.
RESULTS
Tamoxifen Administration Deletes Lrp1
From Essentially All OPCs in the Adult
Mouse Brain
To determine the role that LRP1 plays in regulating adult
myelination, Lrp1 was conditionally deleted from OPCs in
young adult mice. Tamoxifen was administered to P50 control
(Lrp1fl/fl) and Lrp1-deleted (Pdgfrα-CreERTM :: Lrp1fl/fl) mice
and brain tissue examined 7 or 30 days later (at P50+7
and P50+30, respectively). Coronal brain cryosections from
control (Figure 1A) and Lrp1-deleted mice (Figure 1B) were
immunolabeled to detect LRP1 (red) and OPCs (PDGFRα,
green). Consistent with our previous findings (Auderset et al.,
2016a), essentially all OPCs in the corpus callosum of control
mice expressed LRP1 (Figure 1C; P50+7: 99± 0.6%, mean± SD
for n = 4 mice; P50+30: 99.7± 0.3%, mean± SD for n = 3 mice).
However, in the corpus callosum of P50+7 Lrp1-deleted mice,
only 2 ± 0.8% of PDGFRα+ OPCs expressed LRP1 (mean ± SD
for n = 4 mice) and by P50+30, only 0.5 ± 0.5% of OPCs
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 November 2020 | Volume 8 | Article 564351
fcell-08-564351 November 9, 2020 Time: 14:48 # 6
Auderset et al. LRP1 Reduces Adult Mouse Oligodendrogenesis
FIGURE 1 | Lrp1 can be conditionally deleted from adult OPCs at high efficiency. Coronal brain sections from P57+7 and P57+30 control (Pdgfrα-CreERTM) and
Lrp1-deleted (Pdgfrα-CreERTM :: Lrp1fl/fl ) mice were immunolabeled to detect OPCs (PDGFRα, green), LRP1 (red), and cell nuclei (Hoechst 33342, blue). (A–A′′)
Compressed z-stack confocal image of LRP1+ OPCs (solid yellow arrow heads) in the corpus callosum (CC) of a P50+7 control mouse. (B–B′′) Compressed
z-stack confocal image of LRP1-neg OPCs (solid white arrow heads) in the CC of a P50+7 Lrp1-deleted mouse. White arrows indicate PDGFRα-neg cells that
remain LRP1+ in the Lrp1-deleted mice. (C) The proportion (%) of PDGFRα+ OPCs that express LRP1 in P50+7 and P50+30 control and Lrp1-deleted mice
[mean ± SD for n ≥ 3 mice per genotype per time-point; 2-way ANOVA: Genotype F (1,10) = 2.8, p < 0.0001; Time F (1,10) = 0.52, p = 0.5; Interaction F
(1,10) = 3.44, p = 0.09]. Bonferroni multiple comparisons ****p ≤ 0.0001. (D) PCR amplification of genomic DNA extracted from the brain of a P50+7 control
(Lrp1fl/+) and Lrp1-deleted (Pdgfrα-CreERTM :: Lrp1fl/fl ) mouse indicates that recombination, producing the Lrp1 reco band, only occurs in Lrp1-deleted mice. Scale
bars represent 17 µm.
expressed LRP1 (mean ± SD for n = 3 mice; Figure 1C),
confirming the successful deletion of Lrp1 from adult OPCs.
Similarly, in the motor cortex of P50+7 control mice, 100 ± 0%
of PDGFRα+ OPCs expressed LRP1 while only 0.4 ± 0.4%
of PDGFRα+ OPCs expressed LRP1 in the motor cortex of
Lrp1-deleted mice (mean ± SD for n = 4 mice per genotype).
Other brain cell types that express LRP1, such as neurons
and astrocytes, retained their expression of LRP1 (e.g., white
arrows in Figure 1B). As the Cre-mediated recombination of
the floxed Lrp1 gene deletes the extracellular coding region of
Lrp1, recombination was also confirmed by performing a PCR
analysis of genomic DNA from the brains of control (Lrp1fl/+)
and Lrp1-deleted (Pdgfrα-CreERTM :: Lrp1fl/fl) mice after
tamoxifen treatment. Lrp1-deletion enabled the amplification
of a recombination-specific DNA product from Lrp1-deleted
brain DNA that was not amplified from control brain DNA
(Figure 1D). These data confirm that tamoxifen administration
to Pdgfrα-CreERTM :: Lrp1fl/fl transgenic mice efficiently and
specifically deletes Lrp1 from adult OPCs.
Lrp1 Deletion Produces a Delayed
Increase in Adult OPC Proliferation
Oligodendrocyte progenitor cells divide more frequently in white
than gray matter regions of the adult mouse CNS (Psachoulia
et al., 2009) and their homeostatic proliferation ensures that a
stable pool of progenitors is maintained (Hughes et al., 2013).
To determine whether LRP1 regulates the rate that adult OPCs
re-enter the cell cycle to divide or the fraction of adult OPCs
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that proliferate, we delivered a thymidine analog, EdU, to P57+7
control and Lrp1-deleted mice via their drinking water for
2, 4, 6, or 20 days. Coronal brain cryosections from control
(Figures 2A–D) and Lrp1-deleted (Figures 2E–H) mice were
processed to detect PDGFRα+ OPCs (green) and EdU (red).
When quantifying the proportion of OPCs that became EdU
labeled over time, we found that 20 days of EdU-delivery resulted
in EdU uptake by all OPCs in the corpus callosum of control
and Lrp1-deleted mice (100 ± 0 and 100 ± 0%, respectively),
indicating that the proportion of OPCs that can proliferate is
not influenced by LRP1 signaling. Furthermore, the rate of EdU
incorporation was equivalent for OPCs in the corpus callosum of
control and Lrp1-deleted mice (Figure 2I), suggesting that LRP1
does not influence the rate at which OPCs enter or transition
through the cell cycle to become EdU-labeled. OPCs in the
motor cortex incorporated EdU at a slower rate than those in
the corpus callosum (compare the slope of the regression lines
in Figures 2I,J), but OPC proliferation in the motor cortex was
also unaffected by Lrp1-deletion (Figure 2J).
While the loss of LRP1 did not immediately influence OPC
proliferation, LRP1 may regulate receptor and channel recycling
at the cell membrane (Takayama et al., 2005; Liu et al., 2010; Pi
et al., 2012; Maier et al., 2013; Nakajima et al., 2013), such that
Lrp1-deletion may not immediately perturb OPC behavior. To
explore this possibility, we delivered tamoxifen to young adult
(P57) control and Lrp1-deleted mice and waited 28 days before
administering EdU via the drinking water for 4 consecutive days.
Coronal brain cryosections from P57+32 control (Figure 2K)
and Lrp1-deleted (Figure 2L) mice were processed to detect
PDGFRα+ OPCs (green) and EdU (red). The proportion of
OPCs that incorporated EdU over the 4-day labeling period was
significantly higher in the corpus callosum of Lrp1-deleted mice
than controls (Figure 2M). This was also true in the motor
cortex, where 15.0± 1.02% of control and 20.1± 2.53% of Lrp1-
deleted OPCs had incorporated EdU (mean ± SD for n = 3 mice
per genotype; unpaired t-test, p = 0.03). This increase in OPC
proliferation was not accompanied by a change in the density of
PDGFRα+ OPCs (Figure 2N), suggesting that the additional cells
must either differentiate or die.
Lrp1 Deletion Increases the Number of
New OLs Added to the Adult Mouse
Brain
To determine whether LRP1 regulates OL production by adult
OPCs, tamoxifen was given to P57 control (Pdgfrα-CreERTM
:: Rosa26-YFP) and Lrp1-deleted (Pdgfrα-CreERTM :: Rosa26-
YFP :: Lrp1fl/fl) mice to fluorescently label adult OPCs and the
new OLs they produce. At P57+14, coronal brain cryosections
were immunolabeled to detect YFP (green), PDGFRα (red),
and OLIG2 (blue) and confirm the specificity of labeling
(Supplementary Figure 1). Consistent with our previous findings
in control mice (O’Rourke et al., 2016), all YFP+ cells in
the corpus callosum of control and Lrp1-deleted mice were
either PDGFRα+ OLIG2+ OPCs or PDGFRα-negative OLIG2+
newborn OLs (Supplementary Figure 1). In the motor cortex,
the vast majority of YFP+ cells expressed OLIG2 (control:
96.2 ± 0.91%; Lrp1-deleted: 94.3 ± 1.02%, mean ± SD for
n = 3 mice per genotype; Supplementary Figure 1). The small
number of YFP+ OLIG2-negative cells identified in the cortex
had the morphological characteristics of neurons, consistent with
previous reports that the Pdgfrα promoter is active in a small
subset of cortical neurons (Clarke et al., 2012). These cells were
excluded from all subsequent analyses.
To determine whether LRP1 influences oligodendrogenesis,
we quantified the proportion of YFP+ cells that were
PDGFRα-negative OLIG2+ newborn OLs in the corpus callosum
(Figures 3A–F) or motor cortex (Figures 3G–L) of P57+7,
P57+14, P57+30 and P57+45 control and Lrp1-deleted mice.
At P57+7 and P57+14 oligodendrogenesis was equivalent in
the corpus callosum of control and Lrp1-deleted mice, however,
by P57+30 a larger proportion of YFP+ cells had become
newborn OLs in the corpus callosum of Lrp1-deleted mice, and
this effect was sustained at P57+45 (Figure 3M). Similarly, for
the first 2 weeks, OL production was equivalent for OPCs in
the motor cortex of control and Lrp1-deleted mice, however,
by P57+30, the proportion of YFP+ cells that were newborn
OLs was higher in the motor cortex of Lrp1-deleted mice than
controls (Figure 3N). This produced a corresponding increase in
the density of new OLs detected in the corpus callosum (control:
107.2 ± 14.9 cells/mm2; Lrp1-deleted: 161.8 ± 27.4 cells/mm2;
mean ± SD, n = 7 control and n = 4 Lrp1-deleted mice; t-test,
p = 0.0005) and motor cortex (control: 42.55 ± 9.2 cells/mm2;
Lrp1-del: 61.34 ± 7.0 cells/mm2; mean ± SD, n = 4 mice
per genotype; t-test, p = 0.004) of P57+30 Lrp1-deleted mice
compared to controls. By performing immunohistochemistry to
detect YFP (green) and the mature OL marker, aspartoacylase
(ASPA, red) (Figures 4A–L), we confirmed that Lrp1-deletion
increased the number of newborn mature OLs added to the adult
mouse corpus callosum and motor cortex (Figure 4M).
Myelinating OLs Produced by
Lrp1-Deleted OPCs Elaborate a Normal
Number of Internodes
As OPCs differentiate, they rapidly downregulate their expression
of PDGFRα, the NG2 proteoglycan and voltage-gated sodium
channels (NaV) (Richardson et al., 1988; Pringle et al., 1989; De
Biase et al., 2010; Kukley et al., 2010; Clarke et al., 2012). They
become highly ramified pre-myelinating OLs that either die or
continue to mature into myelinating OLs and elaborate myelin
internodes (Trapp et al., 1997; Psachoulia et al., 2009; Hughes
et al., 2013; Young et al., 2013; Tripathi et al., 2017; Pitman
et al., 2019). To grossly examine the myelin profile of adult-
born OLs in control and Lrp1-deleted mice, we fluorescently
labeled a subset of OPCs in the adult mouse brain with a
membrane-targeted form of green fluorescent protein (GFP).
We have previously shown that tamoxifen delivery to adult
Pdgfrα-CreERTM :: Tau-GFP mice does not result in the specific
fluorescent labeling of OPCs and their progeny (Pitman et al.,
2019). Therefore, for this experiment, we instead delivered
tamoxifen to adult LE-control (Pdgfrα-CreERT 2 :: Tau-GFP)
and LE-Lrp1-deleted (Pdgfrα-CreERT 2 :: Tau-GFP :: Lrp1fl/fl)
mice. The Pdgfrα-CreERT 2 transgenic mouse (Rivers et al., 2008)
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FIGURE 2 | Adult OPC proliferation increases following Lrp1 deletion. (A–H) Compressed confocal z-stacks from the corpus callosum (CC) of control
(Pdgfrα-CreERTM ) and Lrp1-deleted (Pdgfrα-CreERTM :: Lrp1fl/fl ) mice, immunolabeled to detect OPCs (PDGFRα, green) and EdU (red) after 2, 4, 6, or 20 days of
EdU delivery. (I) Graph of the proportion (%) of OPCs that incorporate EdU, after 2, 4, or 6 days of delivery, in the CC of control (black) and Lrp1-deleted (gray) mice
(n ≥ 3 mice per genotype per time-point). The rate of EdU uptake was unaffected by genotype (p = 0.7; linear regression for controls: m = 9.2 ± 1.8% per day and
R2 = 0.7; linear regression for Lrp1-deleted: m = 10.2 ± 1.8% per day and R2 = 0.8). (J) Graph of the proportion (%) of OPCs that incorporate EdU, after 2, 4, 6, or
20 days of delivery, in the motor cortex of control (black) and Lrp1-deleted (gray) mice (n ≥ 3 mice per genotype per time-point). The rate of EdU uptake was
unaffected by genotype (p = 0.3; linear regression for control: m = 2.9 ± 0.3 cells per day and R2 = 0.9; linear regression for Lrp1-deleted: m = 3.4 ± 0.3 cells per
day and R2 = 0.9). (K,L) Compressed confocal z-stacks from the CC of P57+32 control and Lrp1-deleted mice that received EdU via the drinking water for 4
consecutive days (from P57+28), and were immunolabeled to detect OPCs (PDGFRα, green) and EdU (red). (M) The proportion (%) of OPCs that were EdU labeled
in the CC of P57+32 control mice (black) and Lrp1-deleted mice (gray) that received 4 days of EdU labeling (mean ± SD, n = 3 mice per genotype; unpaired t-test,
**p = 0.008). (N) Quantification of the density of OPCs in the CC of P57+32 control mice (black) and Lrp1-deleted mice (gray) (mean ± SD, n = 3 mice per
genotype; unpaired t-test, p = 0.6). Solid white arrow heads indicate EdU-neg OPCs. Solid yellow arrowheads indicate EdU+ OPCs. Scale bars represent 17 µm
(A–H) or 70 µm (K,L).
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FIGURE 3 | Lrp1 deletion increases the number of new OLs added to the adult mouse corpus callosum and motor cortex. (A–L) Confocal images of the corpus
callosum (CC; A–F) and motor cortex (Ctx; G–L) of P57+7, P57+14, and P57+30 control (Pdgfrα-CreERTM :: Rosa26-YFP) and Lrp1-deleted (Pdgfrα-CreERTM ::
Rosa26-YFP :: Lrp1fl/fl ) mice immunolabeled to detect PDGFRα (red), YFP (green), and the nuclear marker Hoechst 33342 (blue). Solid yellow arrowheads indicate
YFP+ PDGFRα+ OPCs. Solid white arrowheads indicate YFP+ PDGFRα-neg newborn OLs. (M) Graph of the proportion (%) of YFP+ cells that are YFP+
PDGFRα-neg OLIG2+ newborn OLs in the CC of control and Lrp1-deleted mice [mean ± SD for n ≥ 4 mice per genotype per time-point; 2-way ANOVA: Genotype
F (1, 28) = 22.3, p < 0.0001; Time F (3, 28) = 109.7, p < 0.0001; Interaction F (3, 28) = 1.9, p = 0.15]. (N) Graph of the proportion (%) of YFP+ cells that are YFP+
PDGFRα-neg OLIG2+ newborn OLs in the motor cortex of control and Lrp1-deleted mice [mean ± SD for n ≥ 4 mice per genotype per time-point; 2-way ANOVA:
Genotype F (1, 26) = 22.5, p < 0.0001; Time F (3, 26) = 23.4, p < 0.0001; Interaction F (3, 26) = 4.56, p = 0.011]. Bonferroni multiple comparisons: *p < 0.05,
**p < 0.01, ****p < 0.0001. Scale bars represent 17 µm (A–F) and 34 µm (G–L).
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FIGURE 4 | Lrp1 deletion increases the number of newborn ASPA+ OLs in the adult mouse corpus callosum and motor cortex. (A–L) Confocal images from the
corpus callosum (CC; A–F) or motor cortex (Ctx; G–L) of P57+30 control (Pdgfrα-CreERTM:: Rosa26-YFP) and Lrp1-deleted (Pdgfrα-CreERTM:: Rosa26-YFP::
Lrp1fl/fl ) mice that were immunolabeled to detect ASPA (red), YFP (green), and the nuclear marker Hoechst 33342 (HST, blue). Solid yellow arrowheads indicate
YFP+ ASPA+ mature OLs. Solid white arrowheads indicate YFP+ ASPA-neg cells. (M) Quantification of the proportion (%) of YFP+ cells that are YFP+ ASPA+
newborn mature OLs in the CC and Ctx of P57+30 control and Lrp1-deleted mice [mean ± SD for n = 4 mice per genotype; 2-way ANOVA: Genotype F (1,
12) = 125.3, p < 0.0001; Brain region F (1, 12) = 42.1, p < 0.0001; Interaction F (3, 28) = 4.5, p = 0.056]. Bonferroni multiple comparisons: *p < 0.05, ***p < 0.001.
Scale bars represent 30 µm (A–J).
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has a lower recombination efficiency (LE) than the Pdgfrα-
CreERTM transgenic mouse (Kang et al., 2010), so we first
evaluated the efficiency of Lrp1 deletion using this mouse model.
Coronal brain cryosections from P57+30 LE-control and LE-
Lrp1-deleted mice were immunolabeled to detect PDGFRα and
LRP1 (Figures 5A,B). While 100 ± 0% of PDGFRα+ OPCs
expressed LRP1 in the motor cortex of LE-control mice, only
35 ± 9% of PDGFRα+ OPCs expressed LRP1 in the motor
cortex of LE-Lrp1-deleted mice (mean ± SD for n = 3 mice
per genotype). The recombination efficiency was similar in the
corpus callosum with 100 ± 0% of OPCs expressing LRP1
in LE-control mice and only 37 ± 7% in LE-Lrp1-deleted
mice (Figure 5C).
Only ∼65% of OPCs lacked LRP1 in the LE-Lrp1-deleted
mice, but this was sufficient to increase the number of newborn
OLs detected in the brain. When P57+30 LE-control and LE-
Lrp1-deleted mouse brain cryosections were immunolabeled
to detect GFP (green), PDGFRα (red) and OLIG2 (blue)
(Figures 5D,E), we found that the proportion of GFP+ cells
that became PDGFRα-negative OLIG2+ newborn OLs was
significantly elevated in the motor cortex of LE-Lrp1-deleted
mice (56.3 ± 2.06%) compared to control mice (49.2 ± 1.51%,
mean ± SD for n = 4 mice per genotype; unpaired t-test
p = 0.03). Using the membrane targeted GFP to further
subdivide the newborn OLs into premyelinating and myelinating
OLs, we determined that Lrp1 deletion significantly increased
the proportion of GFP+ cells that had become myelinating
OLs (Figure 5F).
Despite the difference in overall cell number, the morphology
of the myelinating OLs added to the brain of control and
Lrp1-deleted mice was equivalent (Figures 5G,H). Our detailed
morphological analysis of individual GFP+ myelinating OLs
in the motor cortex of LE-control and LE-Lrp1-deleted mice
revealed that neither the average number of internodes elaborated
by GFP+ myelinating OLs (Figure 5I) or the mean length of
internodes elaborated by GFP+ myelinating OLs (Figure 5J) was
changed by Lrp1 deletion. Additionally, LRP1 expression did
not influence the length distribution for internodes elaborated
by newborn myelinating OLs in the motor cortex (Figure 5K).
These data indicate that LRP1 negatively regulates the number of
myelinating OLs added to the healthy adult mouse brain but does
not influence their gross myelination profile.
Lrp1 Deletion Does Not Influence NaV,
AMPA Receptor, L- or T-Type VGCC,
PDGFRα or LRP2 Expression by OPCs
LRP1 has the potential to influence a number of signaling
pathways that directly or indirectly regulate oligodendrogenesis.
The conditional deletion of Lrp1 from neurons in vitro and in vivo
increases AMPA receptor turnover and reduces expression of the
GluA1 subunit of the AMPA receptor (Gan et al., 2014). Adult
OPCs express AMPA receptors (Gallo et al., 1996; Gudz, 2006;
Zonouzi et al., 2011) that enhance the survival of premyelinating
oligodendrocytes during development (Kougioumtzidou et al.,
2017) and glutamatergic signaling regulates OPC proliferation,
differentiation (Gallo et al., 1996; Fannon et al., 2015) and
migration (Gudz, 2006). To determine whether LRP1 regulates
AMPA receptor signaling in OPCs we obtained whole cell patch
clamp recordings from GFP-labeled OPCs in the motor cortex
of P57+30 control (Lrp1fl/fl :: Pdgfrα-histGFP) and Lrp1-deleted
(Pdgfrα-CreERTM :: Lrp1fl/fl :: Pdgfrα-histGFP) mice (Figure 6).
OPCs elicit a large inward voltage-gated sodium current (INa) in
response to a series of voltage-steps (Figure 6A). We found that
INa amplitude (Figure 6B) and OPC capacitance (approximation
of cell size; Figure 6C) were not affected by LRP1 expression.
AMPA receptors were subsequently activated by the bath
application of 100 µm kainate, which evoked a large depolarizing
current in control and Lrp1-deleted OPCs (Figures 6D,E). The
amplitude of the evoked current was equivalent for control and
Lrp1-deleted OPCs across all voltages examined (Figure 6E),
suggesting that Lrp1 deletion has no effect on the composition
or cell-surface expression of AMPA/kainate receptors.
LRP1 regulates the cell surface expression and distribution of
N-type voltage gated calcium channels (VGCC) by interacting
with the α2δ subunit (Kadurin et al., 2017). In adult OPCs,
the closely related L-type VGCCs reduce OPC proliferation
in the motor cortex and corpus callosum (Pitman et al.,
2019) and influence OL maturation in vitro (Cheli et al.,
2015). The other major VGCCs expressed by OPCs are T-type
VGCCs (Williamson et al., 1997; Fulton et al., 2010) which are
activated at lower (hyperpolarized) voltages than L-type channels
and inactivate quickly (transient). To determine whether the
cell surface expression of VGCCs is altered following Lrp1
deletion, we performed whole cell patch clamp electrophysiology
and measured the current density (pA/pF) in OPCs from
control and Lrp1-deleted mice (Figures 6F–I). We found that
the VGCC current density was equivalent for OPCs in the
motor cortex of control and Lrp1-deleted mice (Figures 6F,G).
The current density was also equivalent between OPCs from
control and Lrp1-deleted mice when measured currents were
elicited selectively through L-type VGCCs (Figures 6H,I),
indicating that LRP1 does not influence L- or T-type VGCC
expression in adult OPCs.
Tissue plasminogen activator (tPA) is an LRP1 ligand (Bu
et al., 1992; Orth et al., 1992) and its addition to astrocytic
cultures increases PDGF-CC cleavage and activation (Su et al.,
2008). While PDGF-CC is a ligand of PDGFRα, a key
receptor regulating OPC proliferation, survival and migration
(Noble et al., 1988; Richardson et al., 1988; Pringle et al.,
1989), increased mitogenic stimulation would not account for
LRP1 reducing adult OPC proliferation. In other cell types,
LRP1 has instead been shown to influence the cell surface
expression of PDGFRβ (Takayama et al., 2005; Muratoglu et al.,
2010), a receptor that is closely related to PDGFRα. When
performing immunohistochemistry using an antibody against the
intracellular domain of PDGFRα, it is not possible to specifically
quantify the cell surface expression of PDGFRα in OPCs with
and without LRP1, however, we were able to quantify PDGFRα
expression (mean gray value; Figures 6J–L), and determined that
LRP1 did not influence total PDGFRα expression.
The low-density lipoprotein receptor related protein 2 (LRP2)
is a large cell surface receptor that is closely related to LRP1,
with a number of common ligands (Spuch et al., 2012). LRP2
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FIGURE 5 | Lrp1 deletion increases the number of mature, myelinating OLs added to the motor cortex of adult mice. (A,B) Compressed confocal z-stack from the
corpus callosum (CC) of P57+30 LE-control (Pdgfrα-CreERT 2) and LE-Lrp1-deleted (Pdgfrα-CreERT 2 :: Lrp1fl/fl ) mice that were immunolabeled to detect OPCs
(PDGFRα, green), LRP1 (red), and Hoechst 33342 (blue). Solid yellow arrowheads indicate OPCs that express LRP1. Solid white arrowheads indicate OPCs that do
not express LRP1. (C) The proportion (%) of PDGFRα+ OPCs in the CC of LE-control and the LE-Lrp1-deleted mice that express LRP1 (mean ± SD for n = 3 mice
per group; unpaired t-test, ***p < 0.001). (D–E′) Compressed confocal z-stack from the motor cortex (Ctx) of a P57+30 control (LE-Pdgfrα-CreERT 2 :: Tau-mGFP)
mouse immunolabeled to detect PDGFRα (red), GFP (green), and OLIG2 (blue). Solid yellow arrowheads indicate GFP+ PDGFRα+ OLIG2+ OPCs. Solid white
arrowhead indicates a GFP+ PDGFRα-neg OLIG2+ newborn pre-myelinating OL. The white arrow indicates a GFP+ PDGFRα-neg OLIG2+ newborn myelinating OL.
(F) Quantification of the proportion (%) of GFP+ cells that are PDGFRα+ OLIG2+ OPCs, PDGFRα-neg OLIG2+ premyelinating OLs (pre-OLs) and PDGFRα-neg
OLIG2+ myelinating OLs (OLs) [mean ± SD for n = 4 mice per genotype; 2-way ANOVA: Maturation stage F (2,18) = 195.1, p < 0.0001; Genotype F (1,
18) = 0.032, p = 0.85; Interaction F (2, 18) = 17.1, p < 0.0001]. Bonferroni multiple comparisons: *p = 0.046 and ***p = 0.0004. (G–H′) Compressed confocal
z-stack showing GFP+ PDGFRα-neg myelinating OLs in the motor cortex of P57+30 LE-control and LE-Lrp1-deleted mice. (I) The number of internodes elaborated
by individual GFP+ myelinating OLs in the motor cortex of LE-control and LE-Lrp1-deleted mice (mean ± SEM for n ≥ 10 OLs from n = 3 mice per genotype;
Mann–Whitney Test, p = 0.38). (J) The average length of internodes elaborated by individual GFP+ myelinating OLs in LE-control and LE-Lrp1-deleted mice
(mean ± SEM for n ≥ 10 OLs from n = 3 mice per genotype; unpaired t-test, p = 0.67). (K) Cumulative length distribution plot for GFP+ internodes measured in the
motor cortex of P57+30 LE-control and LE-Lrp1-deleted mice (n = 519 LE-control GFP+ internodes and n = 408 LE-Lrp1-deleted GFP+ internodes measured from
n = 3 mice per genotype; K-S test, D = 0.053, p = 0.5). Scale bars represent 34 µm (A,B) or 17 µm (G,H).
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FIGURE 6 | LRP1 does not alter functional NaV, VGCC, or AMPA/kainate receptor expression, or total PDGFRα expression in OPCs. (A) Representative traces of
voltage-gated sodium channels currents (INa) evoked in GFP+ OPCs in the motor cortex of P57+30 control (Pdgfrα-histGFP :: Lrp1fl/fl ) and Lrp1-deleted
(Pdgfrα-CreERTM :: Pdgfrα-histGFP :: Lrp1fl/fl ) mice. (B) Quantification of peak inward INa (n ≥ 8 GFP+ OPCs analyzed from n = 3 mice per genotype; unpaired
t-test, p = 0.8). (C) Quantification of cell capacitance (n ≥ 9 GFP+ OPCs analyzed from n = 3 mice per genotype; unpaired t-test, p = 0.9). (D) Representative trace
from a control GFP+ OPC responding to the bath application of 100 µM kainate. (E) The current density-voltage relationship of AMPA/kainate receptors in control
(n = 3 GFP+ OPCs) and Lrp1-deleted (n = 3 GFP+ OPCs) cells [mean ± SEM; 2-way repeated measures ANOVA: Genotype F (1, 28) = 0.91, p = 0.3; Voltage F (6,
28) = 31.3, p < 0.0001; Interaction F (6, 28) = 0.25, p = 0.9]. (F) Representative traces show the fast inactivating leak subtracted ICa evoked in GFP+ OPCs in
response to a depolarizing step. (G) The current density-voltage relationship for the leak subtracted ICa (peak amplitude) recorded from control cells (dark circles,
n = 11 GFP+ OPCs across n = 3 mice) and Lrp1-deleted cells (gray squares, n = 10 GFP+ OPCs across n = 3 mice) [mean ± SEM; 2-way repeated measures
ANOVA: Genotype F (1, 190) = 2.85, p = 0.09; Voltage F (9, 190) = 23.5, p < 0.0001; Interaction F (9, 190) = 1.14, p = 0.3]. (H) Representative traces show the leak
subtracted ICa L-type evoked in GFP+ OPCs in response to a depolarizing step. (I) The current density-voltage relationship for leak subtracted ICa L-type (mean
sustained current) recorded from control cells (dark circles, n = 7 GFP+ OPCs across n = 3 mice) and Lrp1-deleted cells (gray squares, n = 11 GFP+ OPCs across
n = 3 mice) [mean ± SEM; 2-way repeated measures ANOVA: Genotype F (1, 176) = 1.03, p = 0.3; Voltage F (10, 176) = 66.8, p < 0.0001; Interaction F (10,
176) = 0.62, p = 0.8]. (J,K) Compressed z-stack confocal image of PDGFRα+ OPCs in the motor cortex (Ctx) of P57+30 control and Lrp1-deleted mice. (L) The
mean gray value of PDGFRα staining for individual OPCs measured in the motor cortex of P57+30 control and Lrp1-deleted mice (mean ± SD; n ≥ 24 OPCs
measured across n = 3 mice per genotype; unpaired t-test, p = 0.8). Scale bars represent 17 µm.
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can increase the proliferation of neural precursor cells in the
subependymal zone (Gajera et al., 2010) and the proliferation
and survival of skin cancer cells (Andersen et al., 2015), however,
it is unclear whether cells of the OL lineage express LRP2
(Cahoy et al., 2008; Zhang et al., 2014; Hrvatin et al., 2018),
or whether Lrp1 deletion could alter LRP2 expression. We
examined this possibility by performing immunohistochemistry
on coronal brain cryosections from P57+30 control and
Lrp1-deleted mice to detect LRP2 and PDGFRα or ASPA
(Supplementary Figure 2). We determined that LRP2 is not
expressed by OPCs or OLs in mice of either genotype, despite the
robust expression of LRP2 by Iba1+ microglia (Supplementary
Figure 2). These data indicate that compensation from LRP2
or a change in LRP2 expression by OPCs is not responsible for
the elevated OPC proliferation and differentiation observed in
Lrp1-deleted mice.
Lrp1 Deletion Does Not Alter EdU
Incorporation by OPCs in vitro
Our data suggest that in the healthy adult mice, Lrp1
deletion either increases OPC proliferation which then results
in an increased number of newborn OLs, or increases
OPC differentiation which subsequently triggers a homeostatic
increase in OPC proliferation to maintain the OPC population.
Previous studies have shown that Lrp1 deletion enhances the
proliferation of retinal endothelial cells (Mao et al., 2016)
and reduces the proliferation of cells within embryonic mouse
neurospheres (Safina et al., 2016), while the activation of LRP1
by tPA enhances the proliferation of interstitial fibroblasts (Lin
et al., 2010). To determine whether LRP1 directly suppresses OPC
proliferation, we generated primary OPC cultures from the cortex
of P0–P5 control (Pdgfrα-hGFP) or Lrp1-deleted (Pdgfrα-hGFP:
Lrp1fl/fl) mice. To delete Lrp1 in vitro, we used a cell-permeable
form of Cre-recombinase, TAT-Cre, which is a fusion peptide
of Cre-recombinase and the HIV cell-penetrating TAT peptide.
After 7 days in vitro (DIV), OPCs were incubated with 1 µM
TAT-Cre for 90 min and LRP1 expression was determined at 9
DIV by performing immunocytochemistry to detect PDGFRα
(red), GFP (green), and LRP1 (blue) (Figures 7A,B). Following
Tat-Cre treatment all OPCs cultured from control mice expressed
LRP1, however, only ∼21% of PDGFRα+ OPCs cultured from
Lrp1-deleted mice retained LRP1 expression (Figure 7C). At
the same time-point, additional control and Lrp1-deleted OPC
cultures were exposed to EdU to label all cells that entered the
S-phase of the cell cycle over a 10-h period. By performing
immunocytochemistry to detect GFP (green), LRP1 (red) and
EdU (Figures 7D,E), we found that LRP1 expression did not
influence OPC proliferation in vitro, as the fraction of OPCs
that were EdU+ was equivalent in control and Lrp1-deleted
cultures (Figure 7F).
To determine whether LRP1 activation by ligands could
directly influence OPC proliferation, we added vehicle (MilliQ
water) or the LRP1 ligands tPA (20 nM) or activated α-
2 macroglobulin (∗α2M; 60 mM) to OPC primary cultures
for 10 h, along with EdU (Figures 7G–J). By performing
immunocytochemistry to detect PDGFRα (green) and EdU (red),
we determined that the proportion of OPCs that became EdU-
labeled did not change with the addition of tPA or ∗α2M
(Figure 7J), indicating that LRP1 activation by these ligands is
unable to acutely modify OPC proliferation in vitro.
Lrp1 Deletion Increases the Proportion
of OPCs That Differentiate in vitro
In vitro, OPCs can be triggered to differentiate by withdrawing
the mitogen PDGF-AA and providing triiodothyronine (T3) in
the culture medium. To determine whether Lrp1 deletion can
enhance OPC differentiation, TAT-Cre-treated control and Lrp1-
deleted OPCs were transferred into differentiation medium for
4 days before they were immuno-labeled to detect PDGFRα+
OPCs (red) and MBP+ OLs (green) (Figures 8A,B). We
determined that the proportion of cells that were PDGFRα+
OPCs was reduced in the Lrp1-deleted cultures, while the
proportion of cells that were MBP+ OLs was significantly
increased compared with control cultures (Figure 8C).
To determine whether the ligand activation of LRP1 was
sufficient to suppress OPC differentiation, OPC primary cultures
were transferred into differentiation medium containing vehicle
(MilliQ water), tPA (20 nM) or ∗α2M (60 nM) for 4 days. By
performing immunocytochemistry to detect PDGFRα+ OPCs
and MBP+ OLs (Figures 8D–F) we found that the activation of
LRP1 by tPA or ∗α2M had no impact on the proportion of cells
that differentiated over time (Figure 8G). As ApoE4 produces
an LRP1-dependent increase in Erk and Akt phosphorylation to
increase the number of O4+ OLs produced by differentiating
embryonic mouse neurospheres (Safina et al., 2016), we also
added vehicle (MilliQ water) or ApoE4 (203 nM) to a distinct
set of proliferating and differentiating OPC cultures. We report
that ApoE4 had no effect on the proportion (%) of OPCs that
incorporated EdU (vehicle: 56.2 ± 11.5%; ApoE4: 57.2 ± 7.3%,
mean± SEM for n = 4 independent cultures; paired t-test t = 0.2,
p = 0.8). Furthermore, the proportion (%) of cells that were
MBP+ OLs (vehicle, 29.1 ± 4.3% and ApoE4, 35.9 ± 3.4%) after
4 days of differentiation, was equivalent in vehicle and ApoE4-
treated cultures [mean ± SEM for n = 4 independent cultures;
paired t-test t = 1.0, p = 0.4]. These data suggest that the LRP1
ligands tPA, α2M and ApoE4, do not regulate OPC differentiation
in vitro.
Lrp1 Deletion Increases the Number of
Newborn Mature OLs Added to the
Corpus Callosum During Cuprizone
Feeding
As Lrp1 deletion enhances OL addition to the healthy adult
mouse brain, we next aimed to determine whether the
deletion of Lrp1 from adult OPCs could similarly increase
OL generation in response to OL loss and demyelination.
Control (Pdgfrα-CreERTM :: Rosa26-YFP) and Lrp1-deleted
(Pdgfrα-CreERTM :: Rosa26-YFP :: Lrp1fl/fl) mice received
tamoxifen by oral gavage at P57 and at P57+7 were transferred
onto a diet containing 0.2% (w/w) cuprizone for 5 weeks
to induce significant OL loss, demyelination of the corpus
callosum and oligodendrogenesis. After 5 weeks of cuprizone
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FIGURE 7 | LRP1 does not affect OPC proliferation in vitro. (A–B′′) Tat-Cre-treated OPCs cultured from the cortex of early postnatal control (Pdgfrα-histGFP) and
Lrp1-deleted (Pdgfrα-histGFP :: Lrp1fl/fl ) mice were immunolabeled to detect PDGFRα (red), LRP1 (blue), and GFP (green). (C) Quantification of the proportion (%) of
control and Lrp1-deleted OPCs that express LRP1 48 h after TAT-Cre treatment (mean ± SEM, n ≥ 3 independent cultures per genotype; unpaired t-test,
****p < 0.0001). (D,E) Tat-Cre-treated OPCs from control and Lrp1-deleted mice exposed to EdU for 10 h and immunolabeled to detect GFP (green), LRP1 (red), and
EdU (blue). (F) Quantification of the proportion (%) of control and Lrp1-deleted OPCs that become EdU-labeled over a 10-h period (mean ± SEM, n ≥ 5 independent
cultures per genotype; unpaired t-test, p = 0.3). (G–I′) Compressed confocal z-stack showing OPCs cultured from control mice that were exposed to EdU and either
vehicle (MilliQ water; G,G′ ), 20 nM tPa (H,H′) or 60 nM *α2M (I,I′) for 10 h, before being processed to detect EdU (red) and PDGFRα (green). (J) Quantification of the
proportion (%) of control OPCs that incorporated EdU when treated with vehicle, tPa or *α2M for 10 h (mean ± SEM, n ≥ 4 independent cultures; 1-way ANOVA:
Treatment F (2, 9) = 0.42, p = 0.66). Scale bars represent 17 µm. DIV = days in vitro; tPA = tissue plasminogen activator; *α2M = activated α-2 macroglobulin.
feeding, control and Lrp1-deleted mice were perfusion
fixed and coronal brain cryosections processed to detect
myelin by black-gold staining (Figure 9). We identified
and measured areas of overt demyelination in the corpus
callosum of control and Lrp1-deleted mice (Figures 9A–
D) and found that this represented a smaller proportion of
the corpus callosum in Lrp1-deleted mice compared with
controls (Figure 9E).
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FIGURE 8 | Lrp1 deletion increases OPC differentiation in vitro. (A,B) Control and Lrp1-deleted OPCs were exposed to Tat-Cre, cultured for a further 48-h, and then
transferred to differentiation medium for 4 days. Compressed confocal z-stack showing differentiated control and Lrp1-deleted (Lrp1fl/fl ) OPC cultures
immunolabeled to detect OPCs (PDGFRα, red), OLs (MBP, green), and all cell nuclei (Hoechst 33342, blue). (C) Quantification of the proportion (%) of cells that were
PDGFRα+ OPCs or MBP+ OLs in control and Lrp1-deleted cultures [mean ± SEM for n = 3 independent cultures per genotype; 2-way ANOVA: Cell type F (1,
8) = 212, p < 0.0001; Genotype F (1, 8) = 0.001, p = 0.97; Interaction F (1, 8) = 19.9, p = 0.02]. Bonferroni multiple comparisons: **p = 0.005. (D–F) Compressed
confocal z-stack shows OPCs from control mice that were transferred into differentiation medium and exposed to vehicle (MilliQ water; D), tPa (E), or *α2M (F) for
4 days before being immunolabeled to detect OPCs (PDGFRα, red), OLs (MBP, green), and all cell nuclei (Hoechst 33342, blue). (G) Quantification of the proportion
(%) of OPCs that became PDGFRα+ OPCs or MBP+ OLs after 4 days in differentiation medium with vehicle, tPa or *α2M [mean ± SEM, n = 3 independent cultures
per treatment; 2-way ANOVA: Cell type F (1, 12) = 44.6, p < 0.0001; Treatment F (2, 10) = 0, p = 1; Interaction F (2, 12) = 0.03, p = 0.97]. tPa = tissue plasminogen
activator; *α2M = activated α2 macroglobulin. Scale bars represent 34 µm (A,B) or 17 µm (D–F).
When EdU was delivered via the drinking water from week
2 to week 5 of cuprizone feeding, it was incorporated into
the vast majority of OLIG2+ cells in the corpus callosum
of control and Lrp1-deleted mice (Supplementary Figure 3).
Despite being newborn cells, many of the PDGFRα+ OPCs
(red) and PDGFRα-negative OLIG2+ OLs (blue) within the
corpus callosum of control and Lrp1-deleted mice did not co-
label with YFP (green) (Figures 9F,G), indicating that these cells
were not derived from the YFP+ parenchymal OPC population.
Following cuprizone-induced demyelination, both parenchymal
OPCs (YFP-labeled) and neural stem cell-derived OPCs (YFP-
negative) contribute to OL replacement and remyelination (Xing
et al., 2014). After cuprizone feeding the proportion of OPCs
that were YFP+ parenchymal OPCs was equivalent in the corpus
callosum of control and Lrp1-deleted mice (Figure 9J). As
total OPC density was also unaffected by genotype (838 ± 165
OPCs/mm2 in control and 740± 134 OPCs/mm2 in Lrp1-deleted
corpus callosum; mean ± SD for n = 5 control and n = 3 Lrp1-
deleted mice; unpaired t-test, p = 0.67), the expression of LRP1 by
parenchymal OPCs does not appear to influence OPC production
by neural stem cells.
Following demyelination, YFP+ parenchymal OPCs present
in the corpus callosum of Lrp1-deleted mice lacked LRP1,
however, the YFP-negative neural stem cell-derived OPCs had
intact LRP1 expression (Supplementary Figure 3). Surprisingly,
YFP+ parenchymal OPCs no longer generated more OLs in
Lrp1-deleted mice compared to controls, as 60 ± 15% of
YFP+ cells were PDGFRα-negative OLIG2+ newborn OLs
in the corpus callosum of control mice and 65 ± 5% of
YFP+ cells were PDGFRα-negative OLIG2+ newborn OLs
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FIGURE 9 | Lrp1 deletion increases the number of mature OLs added to the mouse corpus callosum during cuprizone feeding. (A–D) Young adult control
(Pdgfrα-CreERTM :: Rosa26-YFP) and Lrp1-deleted (Pdgfrα-CreERTM :: Rosa26-YFP :: Lrp1fl/fl ) mice were fed a diet containing 0.2% cuprizone for 5 weeks. At the
end of 5 weeks, coronal brain sections were collected and stained with black-gold to visualize myelin in the corpus callosum. Dotted white lines define the lateral
limits of the region of the corpus callosum analyzed. Red dashed lines denote areas of overt demyelination. (E) The proportion (% area) of the corpus callosum with
faint or absent black-gold staining (overt demyelination) in cuprizone-fed control and Lrp1-deleted mice (mean ± SD, n ≥ 4 mice per genotype; unpaired t-test
(Continued)
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FIGURE 9 | Continued
with Welch’s correction, *p = 0.04). (F–I′′) Compressed confocal z-stack shows the corpus callosum in cuprizone-fed control and Lrp1-deleted mice, immunolabeled
to detect YFP (green), PDGFRα (red), and OLIG2 (blue). White dashed lines indicate the dorsal and ventral boundaries of the corpus callosum; yellow arrowheads
indicate YFP+ PDGFRα+ parenchymal OPCs; solid white arrowheads indicate YFP+ PDGFRα-negative newborn OLs; white arrowheads indicate YFP-negative
PDGFRα+ stem cell-derived OPCs. (J) Quantification of the proportion (%) of OPCs in the corpus callosum of cuprizone-fed control and Lrp1-deleted mice that are
YFP+, PDGFRα+ parenchymal OPCs (mean ± SD, n ≥ 3 mice per genotype; unpaired t-test, p = 0.4). (K) Quantification of the proportion of YFP+ cells in the
corpus callosum of cuprizone-fed control and Lrp1-deleted mice that are PDGFRα-negative OLIG2+ newborn OLs (mean ± SD, n ≥ 3 mice per genotype; unpaired
t-test, p = 0.9). (L) Quantification of the density of PDGFRα-negative OLIG2+ OLs in the corpus callosum of cuprizone-fed control and Lrp1-deleted mice
(mean ± SD, n ≥ 4 mice per genotype; unpaired t-test, p = 0.9). (M,N) Single z-plane confocal images showing the corpus callosum of cuprizone-fed control and
Lrp1-deleted mice stained to detect YFP (green), PDGFRα (red), and BCAS1 (blue). Solid yellow arrows indicate parenchymal OPCs (YFP+ PDGFRα+ ± BCAS1).
Solid white arrows indicate newborn premyelinating OLs derived from parenchymal OPCs (YFP+ PDGFRα-neg BCAS1+). Large white arrow indicates newborn
mature OL derived from parenchymal OPCs (YFP+ PDGFRα-neg BCAS1-neg). (O) Quantification of the proportion of YFP+ cells in the corpus callosum of
cuprizone-fed control and Lrp1-deleted mice that are YFP+ PDGFRα-neg BCAS1-neg newborn mature OLs (mean ± SD for n ≥ 3 mice per genotype; unpaired
t-test, t = 9.8, ***p = 0.0002). Scale bars represent 150 µm (A,C), 30 µm (B,D), 100 µm (F,G), 17 µm (H,I), or 20 µm (M,N). LV, lateral ventricle.
in the corpus callosum of Lrp1-deleted mice (Figure 9K;
mean ± SD for n = 5 control and n = 3 Lrp1-deleted
mice). As total OL density was also equivalent in the corpus
callosum of control and Lrp1-deleted mice (Figure 9L), a
change in oligodendrogenesis did not appear to account for
Lrp1-deleted mice having less overt demyelination. However,
by performing immunohistochemistry to detect YFP, the OPC
marker PDGFRα, and Breast Carcinoma Amplified Sequence
1 (BCAS1), a protein expressed by some OPCs and all pre-
myelinating OLs (Fard et al., 2017; Ferreira et al., 2020),
we found that the fraction of YFP+ cells that were mature
OLs (YFP+ PDGFRα-neg BCAS1-neg) was increased in the
corpus callosum of Lrp1-deleted mice compared to controls
(Figures 9M–O). These data suggest that LRP1 expression by
adult OPCs impairs newborn OL maturation in the cuprizone-
injured CNS.
DISCUSSION
Within the OL lineage, LRP1 is highly expressed by OPCs and
is rapidly down-regulated upon differentiation (Cahoy et al.,
2008; Zhang et al., 2014; Auderset et al., 2016a; Fernandez-
Castaneda et al., 2019), suggesting that LRP1 regulates the
function or behavior of the progenitor cells. As LRP1 can
signal in a number of different ways (Lillis et al., 2008;
Auderset et al., 2016b; Bres and Faissner, 2019) and has been
shown to influence cellular behaviors relevant to OPCs, such as
proliferation, differentiation (Boucher et al., 2007; Mao et al.,
2016; Safina et al., 2016) and migration (Mantuano et al.,
2010, 2015; Barcelona et al., 2013; Ferrer et al., 2016; Sayre
and Kokovay, 2019), we took a conditional gene deletion
approach to determine whether Lrp1 influenced the behavior
of adult mouse OPCs. We report that Lrp1-deletion produces
a delayed increase in adult OPC proliferation and increases
the number of OPCs that differentiate into mature, myelinating
OLs in the motor cortex and corpus callosum. Lrp1 deletion
does not, however, alter the number or length of internodes
produced by the newborn, myelinating OLs. Furthermore,
during cuprizone-induced demyelination, Lrp1 deletion does
not influence the total number of newborn OLs added to
the corpus callosum, but a larger proportion of the newborn
cells are mature OLs.
Does LRP1 Have a Different Effect on
Developmental and Adult OPCs in the
Healthy CNS?
New OLs are added to the adult mouse CNS throughout life
(Dimou et al., 2008; Rivers et al., 2008; Kang et al., 2010; Zhu et al.,
2011), and when we followed the fate of adult OPCs after Lrp1
deletion, we observed a significant increase in the number of new
OLs added to the corpus callosum and motor cortex at P57+30
and P57+45 (Figure 3). In the healthy adult mouse brain, there
is a significant population of pre-myelinating OLs (Xiao et al.,
2016; Fard et al., 2017) that are constantly turned over, as∼78% of
newly generated pre-myelinating OLs survive for less than 2 days
(Hughes et al., 2018). However, Lrp1 deletion did not simply
increase the pool of premyelinating OLs, as deleting Lrp1 from
adult OPCs ultimately increased the number of newborn mature
ASPA+ OLs added to the brain (Figure 4). Furthermore, by using
LE-Pdgfrα-CreERT 2 :: Tau-mGFP transgenic mice to visualize the
full morphology of the newly generated OLs, we were able to
confirm that Lrp1 deletion effectively increased the number of
newborn OLs that had myelinating morphology (Figure 5). The
gross myelination profile of individual myelinating OLs appeared
unaffected by LRP1 expression, as OLs in the cortex of Lrp1-
deleted mice supported the same number of internodes of an
equivalent length as those elaborated by newborn myelinating
OLs in the cortex of control mice (Figure 5).
These data suggest that LRP1 expression by adult OPCs has
the capacity to influence the number of OPCs that differentiate
and survive as newborn, myelinating OLs in the healthy mouse
brain, without significantly impacting their gross myelination
profile. This was unexpected, as it suggests that LRP1 plays a
different role in adult OPCs compared with developmental OPCs.
In the developing mouse optic nerve, deleting Lrp1 from cells of
the OL lineage (Olig2-Cre :: Lrp1fl/fl) reduces the number of OLs
produced and results in hypomyelination by P21 (Lin et al., 2017).
As LRP1 is expressed by radial glia and neural stem cells (Hennen
et al., 2013; Safina et al., 2016; Auderset et al., 2016a), and the
Olig2 gene promoter can be active in some neural stem cells and
transiently active in some astrocytes (Marshall et al., 2005; Cai
et al., 2007), it is possible that the Olig2-Cre transgenic mouse
results in the unintended deletion of Lrp1 from some neural stem
cells. This would be expected to reduce OL generation, as cultured
embryonic NSPCs lacking Lrp1 produce fewer cells of the OL
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lineage (Hennen et al., 2013; Safina et al., 2016). However, a series
of in vitro experiments suggest that the constitutive loss of Lrp1
from OPCs in development, results in longer-lasting detrimental
changes within the lineage. After 2 days of differentiation,
primary brain OPCs derived from early postnatal Olig1-Cre and
Olig1-Cre :: Lrp1fl/fl mice, have an equivalent level of Myrf, Mbp,
and CNPase mRNA expression (Fernandez-Castaneda et al.,
2019), Similarly, after 3 days in differentiation medium, OPCs
from control and conditionally-deleted (Olig2-Cre :: Lrp1fl/fl)
mice contain an equivalent number of NG2+ OPCs or CNPase+
OLs (Lin et al., 2017). By 5 days of differentiation, however,
cultures from the conditionally-deleted mice contain significantly
fewer PLP+ or MBP+ OLs and these cells had impaired myelin
biogenesis (Lin et al., 2017). Sterol-regulatory element binding
protein-2 expression was elevated and peroxisomal biogenesis
factor-2 expression reduced in cultures generated from Olig2-
Cre :: Lrp1fl/fl mice, but the combined delivery of cholesterol and
pioglitazone rescued this phenotype (Lin et al., 2017). Therefore,
it is likely that LRP1 plays an important role in cholesterol
homeostasis and peroxisome biogenesis in developmental OPCs
(Lin et al., 2017). As Lrp1 deletion did not disrupt the gross
myelinating morphology of newborn OLs added to the adult
mouse CNS, this function of LRP1 does not appear to be
retained by adult OPCs. However, this could only be truly
ruled out by performing an ultrastructural analysis of the newly
elaborated myelin.
Why Does Lrp1 Deletion Have a Delayed
Effect on OPC Proliferation in the
Healthy Adult Mouse CNS?
At any one time, the majority of OPCs in the healthy adult mouse
CNS are in the G0 phase of the cell cycle (Psachoulia et al., 2009).
In young adulthood, all OPCs in the corpus callosum re-enter the
cell cycle and divide at least once in a 10-day period, but a similar
level of turnover takes ∼38 days for OPCs in the cortex (Young
et al., 2013). In this study, we found that Lrp1-deletion increased
the rate at which OPCs re-entered the cell cycle and became
EdU-labeled, but the onset of this phenotype was not coincident
with the loss of LRP1 (Figures 1, 2). More specifically, when
EdU labeling commenced at P57+7, the proportion of OPCs that
became EdU labeled over time was the same for control and
Lrp1-deleted mice (Figure 2). However, when EdU delivery was
delayed and instead commenced at P57+28, the proportion of
OPCs that incorporated EdU was elevated in the corpus callosum
or motor cortex of Lrp1-deleted mice compared with controls. It
is feasible that LRP1 directly suppresses adult OPC proliferation.
LRP1 is known to modulate the proliferation of other cell types
(Boucher et al., 2007; Basford et al., 2009; Mao et al., 2016; Safina
et al., 2016; Yang et al., 2018; Zucker et al., 2019), suppressing
the hypoxia-induced proliferation of mouse and human retinal
endothelial cells by regulating the activity of poly (ADP-ribose)
polymerase-1 (PARP-1; Mao et al., 2016), and suppressing the
proliferation of cultured mouse vascular smooth muscle cells by
reducing PDGFRβ activity (Boucher et al., 2003; Basford et al.,
2009). However, the inability of Lrp1 deletion to acutely influence
OPC proliferation in vivo or directly influence OPC proliferation
in vitro (Figure 7; Lin et al., 2017), may suggest that LRP1 affects
OPC proliferation indirectly.
OPC proliferation is intimately linked to OPC differentiation
in vivo (Hughes et al., 2013). As the number of new OLs detected
in the adult mouse brain increases following the conditional
deletion of Lrp1 (Figures 3–5), it is possible that Lrp1-deletion
directly enhances OPC differentiation and, in doing so, produces
a homeostatic increase in OPC proliferation (see Figure 10).
Further supporting this idea, the deletion of Lrp1 from OPCs
in vitro, directly increased the number of MBP+ OLs generated
(Figure 8).
How Does LRP1 Expression by Adult
OPCs Affect OL Production in Response
to an Injury?
As Lrp1 deletion increased the number of new OLs detected in
the healthy adult mouse brain, we predicted that Lrp1 deletion
would also enhance the number of new OLs produced in
response to OL loss. However, OPCs can behave differently
in the healthy versus injured CNS. It was previously reported
that the delivery of tamoxifen to adult CAG-CreERTM ::
Lrp1fl/fl mice, which reduced LRP1 expression by ∼50%,
reduced the remyelination of a lysolecithin-induced callosal
lesion (Hennen et al., 2013). This could have been the result
of LRP1 loss from OPCs, microglia, astrocytes or neurons
(May et al., 2004; Casse et al., 2012; Chuang et al., 2016;
Yang et al., 2016; Liu et al., 2017; He et al., 2020), however, focal
lesion repair was also impaired when Lrp1 was conditionally
deleted from adult OPCs (Pdgfrα-CreERTM :: Lrp1fl/fl mice)
(Hennen et al., 2013). While the level and specificity of Lrp1
deletion was not reported in this study, these data suggest that
LRP1 signaling in adult OPCs could improve myelin repair
(Hennen et al., 2013).
We report that LRP1 experts an altogether different effect
on adult OPCs following cuprizone-mediated OL loss and
demyelination. By performing cre-lox lineage tracing to follow
the fate of adult OPCs, we were able to quantify the number
of new OLs added to the corpus callosum of control and Lrp1-
deleted mice during cuprizone feeding. While the number of
OPC-derived OLs was equivalent in control and Lrp1-deleted
mice, a larger proportion of the new OLs had matured in the
corpus callosum of Lrp1-deleted mice. Furthermore, the area of
the corpus callosum showing overt demyelination was reduced in
Lrp1-deleted mice compared with controls. Consistent with our
findings, adult Olig1-Cre and Olig1-Cre: Lrp1fl/fl mice, subjected
to 5 weeks of cuprizone feeding also had an equivalent number
of OLs in the corpus callosum, however, within 3.5 days of
cuprizone withdrawal, the corpus callosum of Olig1-Cre: Lrp1fl/fl
mice contained more OLs than controls and had greater MBP
coverage (Fernandez-Castaneda et al., 2019). Cuprizone-induced
demyelination is a robust stimulus for OPC differentiation (Xing
et al., 2014; Baxi et al., 2017) and could readily mask the lesser
effect of Lrp1 deletion on new OL addition. These data also
suggest that LRP1 expression by OPCs impair newborn OL
maturation, which could reflect a cell intrinsic function of LRP1
within the OL lineage or could reflect an alternative role for LRP1
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FIGURE 10 | LRP1 signaling in adult OPCs may have cell autonomous and non-cell autonomous effects on myelination and remyelination. Cell autonomous: in vivo,
LRP1 signaling by adult mouse OPCs reduces OPC proliferation and the number of newborn OLs added to the brain. As LRP1 suppresses OPC differentiation
in vitro, we propose that LRP1 can directly suppress OPC differentiation. This cell autonomous effect would also be expected to reduce OPC proliferation, as these
processes are closely and homeostatically linked in vivo. Non-cell autonomous: during cuprizone-induced demyelination, LRP1 expression by OPCs hinders OL
maturation. This may be the result of a cell autonomous function of LRP1 in adult OPCs that has lasting effects during differentiation, but may also be the result of a
less direct signaling mechanism. For example, the release of soluble LRP1 from the surface of OPCs; the LRP1-directed secretion of proteins from OPCs; or an
LRP1-directed increase in OPC-mediated antigen presentation could influence the maturation of pre-myelinating OLs or the behavior of other cell types such as
microglia, astrocytes or lymphocytes.
allowing OPCs to regulate the maturation of adjacent maturing
OLs by a less direct, perhaps inflammatory mechanism (see
Figure 10).
Neuroinflammation impairs OL generation (Miron et al.,
2011) and OPCs can modulate neuroinflammation, releasing
cytokines in response to interleukin 17 receptor signaling
(Wang et al., 2017). OPCs also express genes associated with
antigen processing and presentation (Falcao et al., 2018; Kirby
et al., 2019). While this was not investigated here, previous
research has shown that LRP1 can bind and phagocytose
myelin debris (Gaultier et al., 2009; Fernandez-Castaneda et al.,
2013; Stiles et al., 2013) and that LRP1 expression by OPCs
can influence the inflammatory nature of the remyelinating
environment (Fernandez-Castaneda et al., 2019). RNA profiling
of the remyelinating corpus callosum of Olig1-Cre and Olig1-
Cre: Lrp1fl/fl mice, 3.5 days after cuprizone withdrawal, revealed
that inflammatory gene expression was lower in Olig1-Cre ::
Lrp1fl/fl mice (Fernandez-Castaneda et al., 2019). As LRP1 can be
cleaved, it is possible that OPCs release soluble, cleaved LRP1 to
enhance the inflammatory response of nearby microglia (Brifault
et al., 2017, 2019). However, LRP1 may also facilitate antigen
presentation by OPCs, as the deletion of Lrp1 from OPCs reduces
their expression of MHC class I antigen presenting genes in the
corpus callosum of cuprizone-demyelinated mice and reduces the
ability of OPCs to cross-present antigens to lymphocytes in vitro
(Fernandez-Castaneda et al., 2019). Therefore, further research
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is required to fully elucidate the cell autonomous effect of LRP1
expression in OPCs and the capacity for LRP1 signaling on OPCs
to influence the behavior of other nearby CNS cell types.
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